Replimune Group faces a pivotal FDA decision for RP1 in advanced melanoma, with a Sell rating reflecting approval odds and the current price. Learn more about REPL stock here.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The West Virginia State Penitentiary, a former maximum-security prison that once held far more inmates than it was built for, continues to draw thousands of vis ...

WTOV NBC 9 provides local news, weather forecasts, notices of events and items of interest in the community, sports and entertainment programming for Steubenville and nearby towns and communities in ...

Baker Brothers’ Q1 2026 13F portfolio rose to $17.42B, with top five holdings—Incyte, BeOne Medicines, Insmed, Madrigal ...

Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.

Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal fourth ...

Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the questions I get more than any other is, “Jonathan, how do you ...

Grace Kim's amazing chip shot last year which eventually led to her winning the Evian Championship in a playoff. The Aussie was in a playoff with Jeeno Thitikul and dunked her second shot into the ...

Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest for each option strike price and expiration month. Nasdaq provides call and ...

Arsenal are ready to accelerate talks for Christos Tzolis after being given the green light ...